M. S. Khlestkina

Pharmacological Approaches to Limit Ischemic and Reperfusion Injuries of the Heart: Analysis of Experimental and Clinical Data on P2Y12 Receptor Antagonists

A. Boshchenko, S. Popov, V. Ryabov, 2022, Korean circulation journal.

Regulation of autophagy of the heart in ischemia and reperfusion

A. Boshchenko, S. Popov, L. Maslov, 2022, Apoptosis.

Apelin Is a Prototype of Novel Drugs for the Treatment of Acute Myocardial Infarction and Adverse Myocardial Remodeling

S. Popov, L. Maslov, A. Gorbunov, 2023, Pharmaceutics.

The role of reactive oxygen species and redoxsensitive protein kinases in the infarction-limiting effect of opioid peptide deltorphin II in cardiac reperfusion in rats

M. Sirotina, S. Popov, L. Maslov, 2023, Acta Biomedica Scientifica.

δ-Opioid receptor as a target for the creation of peptide drugs that increase cardiac resistance to reperfusion

S. Popov, L. Maslov, N. Naryzhnaya, 2023, The Siberian Journal of Clinical and Experimental Medicine.

The Role of P2Y6 Receptors in the Mechanisms of the Neuroprotective Effect of Citicoline

L. Maslov, A. Mukhomedzyanov, G. Sufianova, 2023, Bulletin of Experimental Biology and Medicine.

The role of erythropoietin in the regulation of cardiac tolerance to impact of ischemia and reperfusion

L. Maslov, A. Gorbunov, A. Mukhomedzyanov, 2023, The Siberian Journal of Clinical and Experimental Medicine.

Apelin is a peptide increasing tolerance of organs and cells to ischemia and reperfusion. The molecular mechanism (the review)

S. Popov, A. Krylatov, A. Gorbunov, 2024, The Siberian Journal of Clinical and Experimental Medicine.